CACrown ArchivesThe cinema collection
Menu
Research dossier · General Reference

Blood Cells, Molecules and Diseases

journal

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionDec 21, 2025
Entity authorityQ15758051 ↗
Source-derived summary

Blood Cells, Molecules and Diseases is a peer-reviewed medical journal covering hematology. It was established in 1975 as Blood Cells and obtained its current title in 1995. The editor-in-chief is Mohandus Narla. It is published eight times per year by Elsevier.

Abstracting and indexing

The journal is abstracted and indexed in:

According to the Journal Citation Reports, the journal had a 2013 impact factor of 2.331, ranking it 39th out of 68 journals in the category "Hematology".

Editorial summary

This brief starts where responsible research should: with the source description of “Blood Cells, Molecules and Diseases” as journal. Everything that follows is an evidence route, not borrowed authority.

Editorial reviewA practical starting point whose main value is the path it opens into stronger specialist and primary sources. The current lead gives the account dated anchors—1975, 1995, 2013—that can be checked directly. The linked authority record independently contributes the date 1975-01-01. The account is most persuasive where Blood, Cells and Molecules can be independently traced.
Editorial analysis

Why this record matters

The subject matters to the general reference register because the source frames it as journal. Its deeper value depends on whether names, dates, institutions and citations support that framing.

Evidence profile

Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Dec 21, 2025. The linked authority identifier is Q15758051. 6 of 6 selected statements include explicit references; 2 carry qualifiers and 0 use preferred rank. The first chronological checks are 1975, 1995 and 2013.

Critical limits

Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Blood Cells, Molecules and Diseases”, its source revision and the description used here.
  2. Expand the search: follow Blood Cells, Molecules and Diseases primary sources, Blood Cells, Molecules and Diseases archive and Blood research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Blood Cells, Molecules and Diseases”?
  2. Which institution is responsible for the underlying evidence?
  3. Which cited source is closest to the event, object or claim?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Blood Cells, Molecules and Diseases” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.